BioDelivery Sciences International, Inc.

(NASDAQ:BDSI)

2.51

0.00 (0.00%)

Dec 02 - Close

Open
2.50
High
2.51
Low
2.40
Vol.
5.03K
Mkt Cap
48.11M
52Wk High
4.74
52Wk Low
1.57
Avg. Vol.
30.20K
P/E (Trailing)
-4.11
Beta
0.59
Short %
0.10%
Div. Yield
—

After-Hours 2.52 +0.01 (0.40%) Tue, 2 Dec 2008 7:40 PM

Company Profile

BioDelivery Sciences International, Inc.

801 Corporate Center Drive

Raleigh, -2 27607

United States - Map

Phone: (919) 582-9050

Fax: (919) 582-9051

Website: www.bdsinternational.com

State of incorporation: Delaware

CEO: Dr. Mark A. Sirgo, Pharm.D.

Employees: 21

Sector: Healthcare

Industry Group: Drugs

Industry: Biotechnology

Biopharmaceutical company focused on drug delivery

A biopharmaceutical company that is utilizing its licensed, owned and proprietary patented drug delivery technologies to develop and commercialize, either on its own or in partnerships, clinically significant new formulations of proven therapeu

Recent news for BDSI

Recent opinions on BDSI

No recent Opinions for BDSI

No members own BDSI

Members owning BDSI also own

RTK (100.00%), CPSL (100.00%), DPTR (100.00%), MGI (100.00%)

Member sentiment: Neutral